Personalized (N-of-1) Clinical Trials for Inflammatory Bowel Disease: Opportunities and Challenges

This publication has 40 references indexed in Scilit:

• Ulcerative colitis
  The Lancet, 2023
• A Useful and Sustainable Role for N‐of‐1 Trials in the Healthcare Ecosystem
  Clinical Pharmacology & Therapeutics, 2021
• N-of-1 trials are a tapestry of heterogeneity
  Journal of Clinical Epidemiology, 2016
• Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: The case of palliative care
  Journal of Clinical Epidemiology, 2011
• N-of-1 clinical trials should be incorporated into clinical practice
  Journal of Clinical Epidemiology, 2010
• Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations
  Journal of Clinical Epidemiology, 2010
• Marketing therapeutic precision: Potential facilitators and barriers to adoption of n-of-1 trials
  Contemporary Clinical Trials, 2009
• Heterogeneity of Treatment Effects: Implications for Guidelines, Payment, and Quality Assessment
  The American Journal of Medicine, 2007
• Testing nicotine gum for ulcerative colitis patients
  Digestive Diseases and Sciences, 1990
• Clinical trials designed to evaluate therapeutic preferences
  Statistics in Medicine, 1984